Cristofanilli M, Rugo HS, Im SA, Slamon DJ, et al. Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study. Clin Cancer Res 2022;28:3433-3442.
PMID: 35552673